New national guidelines say millions more Americans should get screened for lung cancer. The test can save lives, but it's inaccessible to many and harmful to some. How should we balance the promise and perils of lung cancer screening?Guests:Otis Brawley, MD, Professor of Oncology, Johns Hopkins University School of MedicineLisa Carter-Harris, PhD, APRN, Behavioral Scientist and Adult Nurse Practitioner, Memorial Sloan Kettering Cancer CenterCherie Erkmen, MD, Professor of Thoracic Surgery and Director, Lung Cancer Screening Program, Temple UniversityElla Kazerooni, MD, Professor of Radiology, University of MichiganIda Pittman, lung cancer patient, Temple University Hospital Helena Price, Ida’s cousin and health care advocateGerard Silvestri, MD, Professor of Pulmonology, Medical University of South CarolinaDig deeper into the research and tradeoffs of lung cancer on our website: https://tradeoffs.org/2021/05/27/catching-americas-top-cancer-killer/Take our short listener survey, and you could win a $50 gift card! bit.ly/TradeoffsSurveySign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod
See acast.com/privacy for privacy and opt-out information.
May 27, 2021